Echocardiographic Predictors of All-Cause Mortality in Patients with Hypertrophic Cardiomyopathy following Pacemaker Implantation
Objectives. To examine the association between the echocardiographic parameters measured as left atrial diameter (LAD) and left ventricular end-diastolic diameter (LVEDD) and long-term risk of all-cause mortality in adults with hypertrophic cardiomyopathy (HCM) following pacemaker implantation. Meth...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Cardiology Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2020/2923767 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850164316963078144 |
|---|---|
| author | Nixiao Zhang Wei Hua Xiaoping Li Yiran Hu Hongxia Niu Chi Cai Min Gu Xuhua Chen Shu Zhang |
| author_facet | Nixiao Zhang Wei Hua Xiaoping Li Yiran Hu Hongxia Niu Chi Cai Min Gu Xuhua Chen Shu Zhang |
| author_sort | Nixiao Zhang |
| collection | DOAJ |
| description | Objectives. To examine the association between the echocardiographic parameters measured as left atrial diameter (LAD) and left ventricular end-diastolic diameter (LVEDD) and long-term risk of all-cause mortality in adults with hypertrophic cardiomyopathy (HCM) following pacemaker implantation. Methods. A total of 94 adult patients with HCM who underwent pacemaker implantation from November 2002 to June 2013 in our Arrhythmia Center for symptomatic bradycardia and did not receive an implantable cardiac defibrillator (ICD) or cardiac resynchronization therapy (CRT) during follow-up were retrospectively extracted. Results. After careful examination of the medical records, we retrospectively evaluated the clinical characteristics of 74 patients with LAD records (58.1 ± 14.9 years) and 76 patients with LVEDD records (57.6 ± 15.2 years). Based on the receiver-operating characteristic (ROC) curve, the values of LAD = 44 mm and LVEDD = 43 mm were identified to predict the all-cause mortality. In the Kaplan–Meier survival, LAD ≥44 mm and LVEDD ≥43 mm were both significantly associated with all-cause mortality (log-rank test P<0.05). Cox regression analysis indicated that LAD ≥44 mm (HR 3.580; 95% CI = 1.055–12.148; P=0.041) was an independent predictor of all-cause mortality, while LVEDD ≥43 mm was not significantly associated with all-cause mortality. LVOTO was also significantly associated with all-cause mortality (HR = 0.166; 95% CI = 0.036–0.771; P=0.022). Conclusions. In HCM patients with pacemaker implantation, LAD ≥44 mm was an independent predictor of all-cause mortality. |
| format | Article |
| id | doaj-art-ea8f249d95a8459a84931af780e3b4e9 |
| institution | OA Journals |
| issn | 2090-8016 2090-0597 |
| language | English |
| publishDate | 2020-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Cardiology Research and Practice |
| spelling | doaj-art-ea8f249d95a8459a84931af780e3b4e92025-08-20T02:22:01ZengWileyCardiology Research and Practice2090-80162090-05972020-01-01202010.1155/2020/29237672923767Echocardiographic Predictors of All-Cause Mortality in Patients with Hypertrophic Cardiomyopathy following Pacemaker ImplantationNixiao Zhang0Wei Hua1Xiaoping Li2Yiran Hu3Hongxia Niu4Chi Cai5Min Gu6Xuhua Chen7Shu Zhang8Cardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, ChinaCardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, ChinaHospital of the University of Electronic Science and Technology of China and Sichuan Provincial People’s Hospital, Chengdu 610072, ChinaCardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, ChinaCardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, ChinaCardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, ChinaCardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, ChinaCardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, ChinaCardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, ChinaObjectives. To examine the association between the echocardiographic parameters measured as left atrial diameter (LAD) and left ventricular end-diastolic diameter (LVEDD) and long-term risk of all-cause mortality in adults with hypertrophic cardiomyopathy (HCM) following pacemaker implantation. Methods. A total of 94 adult patients with HCM who underwent pacemaker implantation from November 2002 to June 2013 in our Arrhythmia Center for symptomatic bradycardia and did not receive an implantable cardiac defibrillator (ICD) or cardiac resynchronization therapy (CRT) during follow-up were retrospectively extracted. Results. After careful examination of the medical records, we retrospectively evaluated the clinical characteristics of 74 patients with LAD records (58.1 ± 14.9 years) and 76 patients with LVEDD records (57.6 ± 15.2 years). Based on the receiver-operating characteristic (ROC) curve, the values of LAD = 44 mm and LVEDD = 43 mm were identified to predict the all-cause mortality. In the Kaplan–Meier survival, LAD ≥44 mm and LVEDD ≥43 mm were both significantly associated with all-cause mortality (log-rank test P<0.05). Cox regression analysis indicated that LAD ≥44 mm (HR 3.580; 95% CI = 1.055–12.148; P=0.041) was an independent predictor of all-cause mortality, while LVEDD ≥43 mm was not significantly associated with all-cause mortality. LVOTO was also significantly associated with all-cause mortality (HR = 0.166; 95% CI = 0.036–0.771; P=0.022). Conclusions. In HCM patients with pacemaker implantation, LAD ≥44 mm was an independent predictor of all-cause mortality.http://dx.doi.org/10.1155/2020/2923767 |
| spellingShingle | Nixiao Zhang Wei Hua Xiaoping Li Yiran Hu Hongxia Niu Chi Cai Min Gu Xuhua Chen Shu Zhang Echocardiographic Predictors of All-Cause Mortality in Patients with Hypertrophic Cardiomyopathy following Pacemaker Implantation Cardiology Research and Practice |
| title | Echocardiographic Predictors of All-Cause Mortality in Patients with Hypertrophic Cardiomyopathy following Pacemaker Implantation |
| title_full | Echocardiographic Predictors of All-Cause Mortality in Patients with Hypertrophic Cardiomyopathy following Pacemaker Implantation |
| title_fullStr | Echocardiographic Predictors of All-Cause Mortality in Patients with Hypertrophic Cardiomyopathy following Pacemaker Implantation |
| title_full_unstemmed | Echocardiographic Predictors of All-Cause Mortality in Patients with Hypertrophic Cardiomyopathy following Pacemaker Implantation |
| title_short | Echocardiographic Predictors of All-Cause Mortality in Patients with Hypertrophic Cardiomyopathy following Pacemaker Implantation |
| title_sort | echocardiographic predictors of all cause mortality in patients with hypertrophic cardiomyopathy following pacemaker implantation |
| url | http://dx.doi.org/10.1155/2020/2923767 |
| work_keys_str_mv | AT nixiaozhang echocardiographicpredictorsofallcausemortalityinpatientswithhypertrophiccardiomyopathyfollowingpacemakerimplantation AT weihua echocardiographicpredictorsofallcausemortalityinpatientswithhypertrophiccardiomyopathyfollowingpacemakerimplantation AT xiaopingli echocardiographicpredictorsofallcausemortalityinpatientswithhypertrophiccardiomyopathyfollowingpacemakerimplantation AT yiranhu echocardiographicpredictorsofallcausemortalityinpatientswithhypertrophiccardiomyopathyfollowingpacemakerimplantation AT hongxianiu echocardiographicpredictorsofallcausemortalityinpatientswithhypertrophiccardiomyopathyfollowingpacemakerimplantation AT chicai echocardiographicpredictorsofallcausemortalityinpatientswithhypertrophiccardiomyopathyfollowingpacemakerimplantation AT mingu echocardiographicpredictorsofallcausemortalityinpatientswithhypertrophiccardiomyopathyfollowingpacemakerimplantation AT xuhuachen echocardiographicpredictorsofallcausemortalityinpatientswithhypertrophiccardiomyopathyfollowingpacemakerimplantation AT shuzhang echocardiographicpredictorsofallcausemortalityinpatientswithhypertrophiccardiomyopathyfollowingpacemakerimplantation |